{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T18:58:20Z","timestamp":1722970700726},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"China Scientific Main Special Item Foundation","award":["2009ZX09103-036"],"award-info":[{"award-number":["2009ZX09103-036"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejphar.2018.02.036","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T19:39:52Z","timestamp":1519328392000},"page":"17-23","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection"],"prefix":"10.1016","volume":"826","author":[{"given":"Lei","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuainan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huipeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianchao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhufang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.02.036_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1042\/BSR20160385","article-title":"Liver glucose metabolism in humans","volume":"36","author":"Adeva-Andany","year":"2016","journal-title":"Biosci. Rep."},{"issue":"8","key":"10.1016\/j.ejphar.2018.02.036_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/dom.12474","article-title":"Two dose-ranging studies with PF-04937319, a systemic partial activator of glucokinase, as add-on therapy to metformin in adults with type 2 diabetes","volume":"17","author":"Amin","year":"2015","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.ejphar.2018.02.036_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12031-014-0385-5","article-title":"2-NBDG as a marker for detecting glucose uptake in reactive astrocytes exposed to oxygen-glucose deprivation in vitro","volume":"55","author":"Chen","year":"2015","journal-title":"J. Mol. Neurosci."},{"issue":"5631","key":"10.1016\/j.ejphar.2018.02.036_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.301.5631.290","article-title":"Medicine. Drug deals diabetes a one-two punch","volume":"301","author":"Couzin","year":"2003","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ejphar.2018.02.036_bib5","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.53.8.2164","article-title":"Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation","volume":"53","author":"Cuesta-Munoz","year":"2004","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ejphar.2018.02.036_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/bph.12172","article-title":"S 50131 and S 51434, two novel small molecule glucokinase activators, lack chronic efficacy despite potent acute antihyperglycaemic activity in diabetic mice","volume":"169","author":"De Ceuninck","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2018.02.036_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1476-5381.2012.02184.x","article-title":"Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans","volume":"168","author":"De Ceuninck","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2018.02.036_bib8","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.2337\/db11-0341","article-title":"Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin\/NFAT signaling in primary pancreatic islet beta-cells","volume":"60","author":"Demozay","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2018.02.036_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmech.2017.03.042","article-title":"Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia","volume":"133","author":"Deshpande","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2018.02.036_bib10","doi-asserted-by":"crossref","first-page":"e97139","DOI":"10.1371\/journal.pone.0097139","article-title":"The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats","volume":"9","author":"Erion","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ejphar.2018.02.036_bib11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00125-003-1244-z","article-title":"Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance","volume":"46","author":"Ferre","year":"2003","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ejphar.2018.02.036_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-011-2439-3","article-title":"Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat","volume":"55","author":"Futamura","year":"2012","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.ejphar.2018.02.036_bib13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2337\/db09-0070","article-title":"Identification of a novel beta-cell glucokinase (GCK) promoter mutation (\u221271G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans","volume":"58","author":"Gasperikova","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ejphar.2018.02.036_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/humu.10277","article-title":"Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy","volume":"22","author":"Gloyn","year":"2003","journal-title":"Hum. Mutat."},{"issue":"9","key":"10.1016\/j.ejphar.2018.02.036_bib15","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2337\/diabetes.52.9.2433","article-title":"Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations","volume":"52","author":"Gloyn","year":"2003","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.ejphar.2018.02.036_bib16","doi-asserted-by":"crossref","first-page":"14105","DOI":"10.1074\/jbc.M413146200","article-title":"Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young","volume":"280","author":"Gloyn","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5631","key":"10.1016\/j.ejphar.2018.02.036_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1126\/science.1084073","article-title":"Allosteric activators of glucokinase: potential role in diabetes therapy","volume":"301","author":"Grimsby","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejphar.2018.02.036_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/BJ20060811","article-title":"Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor","volume":"399","author":"Hansmannel","year":"2006","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ejphar.2018.02.036_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI77172","article-title":"Glucokinase activity in the arcuate nucleus regulates glucose intake","volume":"125","author":"Hussain","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.ejphar.2018.02.036_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/dom.12586","article-title":"AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes","volume":"18","author":"Katz","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"10","key":"10.1016\/j.ejphar.2018.02.036_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/dom.12100","article-title":"Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus","volume":"15","author":"Kiyosue","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.ejphar.2018.02.036_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ejphar.2018.02.036_bib23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.metabol.2015.06.014","article-title":"Antidiabetic potential of a novel dual-target activator of glucokinase and peroxisome proliferator activated receptor-gamma","volume":"64","author":"Lei","year":"2015","journal-title":"Metabolism"},{"issue":"24","key":"10.1016\/j.ejphar.2018.02.036_bib24","doi-asserted-by":"crossref","first-page":"19926","DOI":"10.18632\/oncotarget.5138","article-title":"Arcuate nucleus glucokinase and dietary glucose intake","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ejphar.2018.02.036_bib25","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.bmcl.2005.01.087","article-title":"Discovery, synthesis and biological evaluation of novel glucokinase activators","volume":"15","author":"McKerrecher","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejphar.2018.02.036_bib26","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/dc11-1200","article-title":"Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes","volume":"34","author":"Meininger","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ejphar.2018.02.036_bib27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00125-012-2521-5","article-title":"Control of beta cell function and proliferation in mice stimulated by small-molecule glucokinase activator under various conditions","volume":"55","author":"Nakamura","year":"2012","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.ejphar.2018.02.036_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0168-8227(95)01161-7","article-title":"Interference by gliclazide in the glucose oxidase\/peroxidase method for glucose assay","volume":"30","author":"Nakashima","year":"1995","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"16","key":"10.1016\/j.ejphar.2018.02.036_bib29","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1021\/jm3008689","article-title":"Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients","volume":"55","author":"Sarabu","year":"2012","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejphar.2018.02.036_bib30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2337\/db08-1792","article-title":"Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations","volume":"58","author":"Sayed","year":"2009","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ejphar.2018.02.036_bib31","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.2337\/db13-0052","article-title":"Glucokinase activation ameliorates ER stress-induced apoptosis in pancreatic beta-cells","volume":"62","author":"Shirakawa","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ejphar.2018.02.036_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2018.02.036_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2011.05.009","article-title":"Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice","volume":"663","author":"Winzell","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2018.02.036_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jcph.589","article-title":"Effects of piragliatin, a glucokinase activator, on fasting and postprandial plasma glucose in patients with type 2 diabetes mellitus","volume":"56","author":"Zhi","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.036_bib35","unstructured":"Zhiqiang, F., Shen, Z., Song, H., Lei, L., Jin, X., Huan, Y., Liu, Q., Liu, S., 2011. Nicotinic acid derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities, INST MATERIA MEDICA CAMS. Publication Patent Number: CN102786468A."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918301201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918301201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T18:21:11Z","timestamp":1535048471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918301201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":35,"alternative-id":["S0014299918301201"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.036","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}